A detailed history of Dimensional Fund Advisors LP transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 194,460 shares of ENTA stock, worth $1.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
194,460
Previous 129,062 50.67%
Holding current value
$1.08 Million
Previous $1.67 Million 20.5%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$10.05 - $16.54 $657,249 - $1.08 Million
65,398 Added 50.67%
194,460 $2.02 Million
Q2 2024

Aug 09, 2024

SELL
$11.43 - $17.02 $688,017 - $1.02 Million
-60,194 Reduced 31.81%
129,062 $1.67 Million
Q1 2024

May 10, 2024

BUY
$10.08 - $17.46 $97,705 - $169,239
9,693 Added 5.4%
189,256 $3.3 Million
Q4 2023

Feb 07, 2024

SELL
$8.18 - $10.78 $140,614 - $185,308
-17,190 Reduced 8.74%
179,563 $1.69 Million
Q3 2023

Nov 09, 2023

SELL
$11.09 - $22.13 $2.76 Million - $5.5 Million
-248,689 Reduced 55.83%
196,753 $2.2 Million
Q2 2023

Aug 09, 2023

SELL
$20.68 - $39.85 $1.93 Million - $3.72 Million
-93,247 Reduced 17.31%
445,442 $9.53 Million
Q1 2023

May 12, 2023

SELL
$38.82 - $54.59 $189,325 - $266,235
-4,877 Reduced 0.9%
538,689 $21.8 Million
Q4 2022

Feb 09, 2023

BUY
$40.77 - $53.73 $1.37 Million - $1.81 Million
33,688 Added 6.61%
543,566 $25.3 Million
Q3 2022

Nov 10, 2022

SELL
$48.29 - $71.27 $667,898 - $985,735
-13,831 Reduced 2.64%
509,878 $26.4 Million
Q2 2022

Aug 12, 2022

SELL
$38.13 - $76.93 $2.66 Million - $5.37 Million
-69,811 Reduced 11.76%
523,709 $24.8 Million
Q1 2022

May 13, 2022

SELL
$56.06 - $74.11 $460,701 - $609,035
-8,218 Reduced 1.37%
593,520 $42.2 Million
Q4 2021

Feb 09, 2022

SELL
$60.19 - $97.37 $549,414 - $888,793
-9,128 Reduced 1.49%
601,738 $45 Million
Q3 2021

Nov 12, 2021

SELL
$41.02 - $58.65 $1.39 Million - $1.99 Million
-33,922 Reduced 5.26%
610,866 $34.7 Million
Q2 2021

Aug 12, 2021

BUY
$43.76 - $53.11 $2.51 Million - $3.04 Million
57,292 Added 9.75%
644,788 $28.4 Million
Q1 2021

May 14, 2021

SELL
$41.69 - $54.95 $3.49 Million - $4.6 Million
-83,725 Reduced 12.47%
587,496 $29 Million
Q4 2020

Feb 25, 2021

BUY
$41.16 - $47.47 $27.6 Million - $31.9 Million
671,221 New
671,221 $28.3 Million

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $115M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.